HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Platelet aggregation and retinal microangiopathy in diabetes and hypertension.

Abstract
Platelet aggregation studies were done in 10 cases of diabetes with and without retinopathy and 7 cases of hypertensive retinopathy with adenosine diphosphate (ADP) and adrenaline (ADR). It was observed that the rate and degree of aggregation was significantly increased in the retinopathy group both with ADP and ADR. A significant alteration in the latent period was found with ADP, whereas no such change was found with ADR. It is proposed that the increased platelet reactivity in retinal microangiopathy could be due to different mechanisms. Increased sensitivity of the platelets to ADP resulting in the rapid inductive phase of aggregation together with accelerated intrinsic ADP release in diabetic retinopathy may cause hyperaggregation of platelets. Hyperaggregation in hypertensive retinopathy, however, may occur due to accelerated ADP release only. Platelet metabolism supporting the release reaction is altered in both.
AuthorsP K Khosla, M Mahabaleswara, H K Tiwari, A K Saraya
JournalActa haematologica (Acta Haematol) Vol. 61 Issue 3 Pg. 161-7 ( 1979) ISSN: 0001-5792 [Print] Switzerland
PMID108893 (Publication Type: Journal Article)
Chemical References
  • Adenosine Diphosphate
  • Epinephrine
Topics
  • Adenosine Diphosphate (pharmacology)
  • Adult
  • Diabetes Mellitus (blood)
  • Diabetic Retinopathy (blood)
  • Epinephrine (pharmacology)
  • Female
  • Humans
  • Hypertension (blood)
  • Male
  • Middle Aged
  • Platelet Aggregation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: